TDG director receives 518 stock options at $1,291.97 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TransDigm Group (TDG) reported a Form 4 for a director, reflecting a grant of stock options for 518 shares on November 4, 2025 with an exercise price of $1,291.97 per share and an expiration date of November 4, 2035.
The options vest at 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets. Following the grant, the reporting person held 518 derivative securities directly. The derivative security is a stock option on TransDigm common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Graff Michael
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 518 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 518 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did TransDigm (TDG) disclose in this Form 4?
A director received stock options for 518 shares on November 4, 2025 at an exercise price of $1,291.97 per share.
What is the vesting schedule for the TDG options?
The options vest 20% per year over five years beginning September 30, 2026, subject to annual operating performance targets.
When do these TDG options expire?
The options expire on November 4, 2035.
What is the ownership form after the transaction?
The reporting person held 518 derivative securities with direct ownership.
What transaction code was used?
Transaction code A indicates an option grant/acquisition.